4.5 Editorial Material

The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

期刊

ACS INFECTIOUS DISEASES
卷 6, 期 6, 页码 1295-1298

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00101

关键词

-

向作者/读者索取更多资源

The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据